Hints and tips:
Related Special Reports
...WPP’s Ogilvy advertising agency is creating a division specialising in online “health influencers” to help pharmaceutical companies tap a trend towards personalised health and combat misinformation....
...The British pharmaceutical company is preparing for a vote on its long-serving leader’s pay at the annual meeting on Thursday, including a rise that would take his package to a maximum of £18.7mn....
...Eli Lilly last week announced a deal to buy a Wisconsin-based production facility for filling its injectable pens from Nexus Pharmaceuticals....
...So effective is Vertex Pharmaceuticals’ blockbuster cystic fibrosis (CF) drug, Trikafta, that studies project it could extend the lives of some young patients by up to 45 years....
...David Haig’s new stage adaptation of Minority Report starts, as does Steven Spielberg’s 2002 action movie, with Philip K Dick’s sci-fi novella....
...In a hefty research note the US investment bank argues that investor sentiment on K-pop is “ripe for a turnaround”....
...A Humira biosimilar from Teva Pharmaceuticals working with Alvotech earlier this year became the first drug that the US Food and Drug Administration granted interchangeable status, which lets pharmacists...
...Still, Delaware, Inc is going to have to decide whether its brand should be based on being an even-handed, dispassionate system or something more corporate-friendly, designed to keep up in a regulatory race...
...If we as a society are serious about women’s rights, then pharmaceutical companies and the wider global health community must ensure that mothers in the 21st century have a better chance than Kaveri of bringing...
...While President Vladimir Putin sought to implicate Ukraine in last week’s attack, a Moscow court specified that all four main suspects were Tajik citizens, a group that forms a significant component of Isis-K...
...In February, the UK pharmaceuticals company hit a long-term sales target that once seemed out of reach....
...Avid Bioservices, a small-cap company that helps develop and manufacture drugs for pharmaceutical companies, filed this with the SEC yesterday: On February 29, 2024, Avid Bioservices, Inc....
...On a busy day at work in 2016, Matthew Panuwat took a break from his biotech executive job to make a stock trade on his computer....
...Isis-K launched a suicide attack against the Russian embassy in Kabul in September 2022. “Isis-K has even rolled out a Russian-language propaganda wing,” Webber said....
...It is grappling with total debt estimated at about €42bn, one of the biggest product liability cases in corporate history, plus a pharmaceuticals growth problem....
...WW lost more than a quarter of a billion dollars in 2022 as its subscriptions dropped more than 15 per cent to 3.5mn, though it did not draw a connection between that reversal and the new drugs....
...The US drugmaker, a top-10 pharma company by sales, relies on WuXi AppTec sister company WuXi Biologics to manufacture some of the active pharmaceutical ingredients in its blockbuster cancer pill Revlimid...
...(Aeon) — Biggest Tory donor said looking at Diane Abbott makes you ‘want to hate all black women’ (The Guardian) — More Americans are using their 401(k)s like cash machines (Wall Street Journal) — The...
...It’s a different story here in the UK – where Aim-listed Celadon Pharmaceuticals believes it’s one of only two firms with the necessary licences to grow and distribute pharmaceutical-grade cannabis....
...Those from Chinese groups Shanghai Benemae Pharmaceutical and Huadong Medicine have recently received approval....
...California has taken a first step to push down pharmaceutical prices in the US state, striking a deal with the maker of a drug that can reverse opioid overdoses to purchase the medicine at a large discount...
...“What’s brilliant about the Philip K Dick story is it’s got a psychological conundrum in the centre of it,” says Webster. “But it’s not a philosophical exercise or lecture; it’s a crime thriller....
...It is struggling to raise enough funding for clinical trials, because metformin is a generic drug, so offers insufficient profit to pharmaceutical companies....
...That holds true for pharmaceutical companies which are looking a bit peaky. Roche, whose stock has fallen 27 per cent in the past 12 months, is a case in point....
...But after years of trying, the pharmaceuticals industry is getting to grips with the multibillion-dollar problem of fatty liver disease....
International Edition